| Mrs Tammy Leah Dorris, MED CCC/SLP | |
|
525 Cumberland Ridge Way, Bowling Green, KY 42103-6002 | |
| (270) 792-3621 | |
| (270) 781-6483 |
| Full Name | Mrs Tammy Leah Dorris |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 525 Cumberland Ridge Way, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649585894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 142993 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tammy Leah Dorris, MED CCC/SLP 525 Cumberland Ridge Way, Bowling Green, KY 42103-6002 Ph: (270) 792-3621 | Mrs Tammy Leah Dorris, MED CCC/SLP 525 Cumberland Ridge Way, Bowling Green, KY 42103-6002 Ph: (270) 792-3621 |
News Archive
Targacept, Inc. today announced top-line results from a Phase 2 clinical trial of AZD1446 conducted by AstraZeneca in adults with attention deficit/hyperactivity disorder (ADHD).
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Scientists from the United States and China have revealed the potential for human stem cells to provide a vaccination against colon cancer, reports a study published in STEM CELLS.
Regado Biosciences, Inc., a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Food and Drug Administration has accepted the company's investigational new drug (IND) application for REG2. Regado previously completed a single escalating-dose Phase 1 clinical trial of REG2 and plans to conduct additional clinical testing in sub-acute venous thrombosis indications in the future.
› Verified 7 days ago
Amanda Sadler, M.S. CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5855 Richpond Rd, Bowling Green, KY 42104 Phone: 270-535-1853 | |
Adair Mcalister, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5079 Scottsville Rd, Bowling Green, KY 42104 Phone: 270-999-4626 | |
Cora Spiller, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1053 Lovers Ln, Bowling Green, KY 42103 Phone: 270-807-0335 | |
Mrs. Miranda Mize Hunt, MS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 5079 Scottsville Rd, Bowling Green, KY 42104 Phone: 270-781-2462 | |
Ashley Marie Sterchi, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: The Kid Spot Center, 944 Fields Dr. #102, Bowling Green, KY 42104 Phone: 270-495-1312 | |
Olivia Grace Jones, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 952 Fairview Ave Ste 4, Bowling Green, KY 42101 Phone: 270-938-0101 | |
Mr. Frank Trevor Polson, MSCCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Shive Ln Ste 104, Bowling Green, KY 42103 Phone: 270-576-3303 |